According to sources from the battery and investment banking (IB) industries on March 24, it has been confirmed that SK on is in the final stages of securing US$1.1 billion in funding.Firstly, SK on secured a US$400 million loan through Shinhan Bank last month, which was then transferred to its U.S.
A huge wave that began with Chinese e-commerce platform AliExpress is now on the horizon, making it to more difficult to predict the future of the Korean e-commerce market.While Korean e-commerce players are competing fiercely for survival, the United States, China, and other Asian countries have jo
KT&G has been recognized as a leading company in the climate change response and water resource management sector by Carbon Disclosure Project (CDP), a global environmental information assessment organization, achieving the Leadership grade.Following last year, the company has once again attained to
Global private equity fund (PEF) Carlyle Group will sell a 1.2 percent stake in KB Financial Group in a block deal worth about 32 billion won.According to sources in the investment banking (IB) industry on Feb. 14, Carlyle Group made a demand forecast after the close of the market to push forward th
On Feb. 7, KB Financial Group was selected as the only domestic financial institution to achieve the highest rating, “Top 1%,” in the “2023 Corporate Sustainability Assessment” announced by U.S.-based Standard & Poor’s Global (S&P Global).The highest rating of “Top 1%” in the “2023 Corporate Sustain
The Ministry of Trade, Industry, and Energy (MOTIE) and the Korea Trade-Investment Promotion Agency (KOTRA) announced on Jan. 28 that they have published the “JP Morgan Healthcare Conference Weekly Expedition Report” as part of their “Overseas Exhibition Information Provision” series.The 42nd JP Mor
Samsung Biologics is expected to continue to post the highest growth rate in the global contract development manufacturing organization (CDMO) industry this year after posting record-high business results in 2023.A consensus forecast for Samsung Biologics’ revenue growth was 22 percent last year, ac
Chairman Seo Jung-jin of Celltrion Group has revealed plans to list the holding company, Celltrion Holdings, on the NASDAQ in the United States.According to the industry sources on Jan. 15, Chairman Seo, who owns 98.5% of Celltrion Holdings, announced these plans while speaking at the Korean Busines
During a press conference at the JP Morgan Healthcare Conference (JPMHC), the world’s largest pharmaceutical and biotech investment event, on Jan. 10 (local time), Celltrion Group Chairman Seo Jung-jin announced that the company plans to establish a healthcare investment fund worth 100 trillion won.
Dong-A ST announced on Jan. 10 that it signed a business agreement with Eleven Therapeutics to develop RNA-based gene therapies. The agreement was finalized at the J.P. Morgan Healthcare Conference in San Francisco on Jan. 9.The collaboration will focus on discovering RNA therapies targeting fibroti
MBK Partners announced that Moon Joo-Ho, the executive director in charge of special situations investments in Korea, was promoted to the position of partner and vice president on Jan. 1.Vice President Moon graduated from Seoul National University with a degree in Business Administration and holds a
The 42nd JP Morgan Healthcare Conference is set to take place from Jan. 8 to 11 in San Francisco, California, in the U.S. This annual event, held every January, is renowned as the world’s largest healthcare investment venue where major global pharmaceutical companies, emerging biotech firms, and pro
The author is an analyst for NH Investment & Securities. He can be reached at pk.park@nhqv.com -- Ed.Gene cell therapy approaches are gradually gaining renewed attention in response to recent CRISPR and CAR-T news. GCT received keen attention in 2H20 as a viral vector and mRNA-based coronavirus vacc
Samsung Biologics announced on Dec. 26 that it will participate in the “2024 J.P. Morgan Healthcare Conference (JPMHC)” taking place from Jan. 8 to 11 in San Francisco, California, in the U.S.John Rim, CEO of Samsung Biologics, is scheduled to present on Jan. 9 at 3:45 p.m. local time in the Grand B
An analysis has emerged suggesting that the Morgan Stanley Capital International (MSCI) Korea Index is poised to experience a 20 percent increase in the coming year.On Nov. 26, Bloomberg Intelligence (BI), a research institution under Bloomberg, projected a 58 percent increase in the total earnings
President Yoon Seok-yeol has announced a prohibition on short selling until fundamental reform measures are established.During his address at the Cabinet meeting held at the Blue House in Yongsan on Nov. 14, President Yoon Seok-yeol stated, “To prevent further damage, we will prohibit short selling
HYOSUNG TNC has significantly advanced, obtaining an AA rating in the Morgan Stanley Capital International (MSCI) Environmental, Social, and Governance (ESG) assessment, a notable improvement from its previous position.The MSCI ESG Ratings are a globally acknowledged benchmark used by leading corpor
In response to criticism suggesting that the ban on short selling implemented on Nov. 6 is a “political decision” aimed at next year’s general election, Lee Bok-hyun, the head of the Financial Supervisory Service (FSS), directly refuted the claims, stating, “About 100 stocks were identified as targe
The financial authorities have played a strong hand with a “full prohibition of short selling” to restore market trust. Unlike the global trend during the COVID-19 crisis, this time, South Korea alone has moved to prohibit short selling, drawing significant attention to the rationale behind this dec
The recent revelation of illegal short selling by global investment banks (IBs) and a plunge in the stock market are fueling a debate on a total ban on short selling of all listed stocks. “We will improve all systems from scratch,” Financial Services Commission (FSC) Chairman Kim Joo-hyun said in re